
Clinical Diagnosis
Latest News
Advertisement
CME Content
Advertisement













Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.











Anatomic changes after RD might help determine best time for surgery

Much has been learned about epidemic keratoconjunctivitis (EKC) since it was first described in 1889.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
2
Collarettes common but largely stable in moderate-to-severe dry eye patients
3
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
4
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
5


















































.png)


